Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

CGP-49823 compares favorably to diazepam in rat model of anxiety

Nov. 21, 1997

Bayer seeks FDA approval for metrifonate for Alzheimer's disease

Nov. 21, 1997

Nortran and Bridge Pharma to develop dermal anesthetics

Nov. 20, 1997

Novartis' NK1 antagonist in clinical studies for pain

Nov. 20, 1997

Pharmacological characterization of CCD-3693, an orally available neuroactive steroid

Nov. 20, 1997

Positive preclinical results obtained with Avigen's antiparkinsonian gene therapy

Nov. 20, 1997

New neurologic drugs from Nippon Kayaku

Nov. 19, 1997

BTG licenses peptide technology to CeNeS

Nov. 19, 1997

Dainippon develops sustained-release morphine preparation

Nov. 18, 1997

Warner-Lambert describes novel anticonvulsants related to gabapentin

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...